These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25186097)

  • 81. Perceptions of Methotrexate Intolerance and Its Impact on Daily Life in School-Age Children with Juvenile Idiopathic Arthritis.
    Khan S; Mancini J; Hopper C; Rennick JE
    J Pediatr Nurs; 2019; 48():49-54. PubMed ID: 31254860
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
    Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
    Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis.
    Khraishi M; Millson B; Woolcott J; Jones H; Marshall L; Ruperto N
    Pediatr Rheumatol Online J; 2019 Sep; 17(1):64. PubMed ID: 31500631
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Lung function in children and adolescents with juvenile idiopathic arthritis during long-term treatment with methotrexate: a retrospective study.
    Leiskau C; Thon A; Gappa M; Dressler F
    Clin Exp Rheumatol; 2012; 30(2):302-7. PubMed ID: 22409955
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.
    Davies R; Southwood TR; Kearsley-Fleet L; Lunt M; Hyrich KL;
    Arthritis Rheumatol; 2015 Sep; 67(9):2487-94. PubMed ID: 25989609
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial.
    Tarkiainen M; Tynjälä P; Vähäsalo P; Kröger L; Aalto K; Lahdenne P
    Pediatr Rheumatol Online J; 2019 Dec; 17(1):80. PubMed ID: 31842940
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate.
    Refsum H; Wesenberg F; Ueland PM
    Cancer Res; 1991 Feb; 51(3):828-35. PubMed ID: 1988122
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis.
    Swart JF; van Dijkhuizen EHP; Wulffraat NM; de Roock S
    Ann Rheum Dis; 2018 Mar; 77(3):336-342. PubMed ID: 29138257
    [TBL] [Abstract][Full Text] [Related]  

  • 89. In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?
    Roszkiewicz J; Smolewska E
    Curr Rheumatol Rep; 2017 Apr; 19(4):19. PubMed ID: 28361333
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA.
    Klotsche J; Minden K; Niewerth M; Horneff G
    Ann Rheum Dis; 2018 Jul; 77(7):996-1002. PubMed ID: 29453217
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Switched Memory B Cells Are Increased in Oligoarticular and Polyarticular Juvenile Idiopathic Arthritis and Their Change Over Time Is Related to Response to Tumor Necrosis Factor Inhibitors.
    Marasco E; Aquilani A; Cascioli S; Moneta GM; Caiello I; Farroni C; Giorda E; D'Oria V; Marafon DP; Magni-Manzoni S; Carsetti R; De Benedetti F
    Arthritis Rheumatol; 2018 Apr; 70(4):606-615. PubMed ID: 29316374
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Low-dose methotrexate treatment for oligoarticular juvenile idiopathic arthritis nonresponsive to intra-articular corticosteroids.
    Brik R; Gepstein V; Berkovitz D
    Clin Rheumatol; 2005 Nov; 24(6):612-4. PubMed ID: 15877178
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The role of liver transaminase levels in methotrexate intolerance in juvenile idiopathic arthritis-a cross-sectional study.
    Wibrand C; Kyvsgaard N; Christensen AE; Herlin T
    Rheumatol Int; 2023 May; 43(5):875-880. PubMed ID: 36922416
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing - treatment protocol and preliminary results.
    Höfel L; Eppler B; Storf M; Schnöbel-Müller E; Haas JP; Hügle B
    Pediatr Rheumatol Online J; 2018 Feb; 16(1):11. PubMed ID: 29433504
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis.
    Papadopoulou C; Kostik M; Böhm M; Nieto-Gonzalez JC; Gonzalez-Fernandez MI; Pistorio A; Martini A; Ravelli A
    J Pediatr; 2013 Sep; 163(3):879-84. PubMed ID: 23664559
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The impact of single nucleotide polymorphisms in ADORA2A and ADORA3 genes on the early response to methotrexate and presence of therapy side effects in children with juvenile idiopathic arthritis: Results of a preliminary study.
    Roszkiewicz J; Michałek D; Ryk A; Swacha Z; Szmyd B; Smolewska E
    Int J Rheum Dis; 2020 Nov; 23(11):1505-1513. PubMed ID: 32969158
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype.
    Moncrieffe H; Hinks A; Ursu S; Kassoumeri L; Etheridge A; Hubank M; Martin P; Weiler T; Glass DN; Thompson SD; Thomson W; Wedderburn LR
    Pharmacogenet Genomics; 2010 Nov; 20(11):665-76. PubMed ID: 20827233
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment.
    Beukelman T; Xie F; Chen L; Baddley JW; Delzell E; Grijalva CG; Lewis JD; Ouellet-Hellstrom R; Patkar NM; Saag KG; Winthrop KL; Curtis JR;
    Arthritis Rheum; 2012 Aug; 64(8):2773-80. PubMed ID: 22569881
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
    Klotsche J; Niewerth M; Haas JP; Huppertz HI; Zink A; Horneff G; Minden K
    Ann Rheum Dis; 2016 May; 75(5):855-61. PubMed ID: 25926155
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Adalimumab versus adalimumab and methotrexate for the treatment of juvenile idiopathic arthritis: long-term data from the German BIKER registry.
    Klein A; Becker I; Minden K; Foeldvari I; Haas JP; Horneff G
    Scand J Rheumatol; 2019 Mar; 48(2):95-104. PubMed ID: 30411654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.